These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36084082)

  • 1. Biperiden for prevention of post-traumatic epilepsy: A protocol of a double-blinded placebo-controlled randomized clinical trial (BIPERIDEN trial).
    Foresti ML; Garzon E; Pinheiro CCG; Pacheco RL; Riera R; Mello LE
    PLoS One; 2022; 17(9):e0273584. PubMed ID: 36084082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-9-5p is Downregulated in Serum Extracellular Vesicles of Patients Treated with Biperiden After Traumatic Brain Injury.
    Villena-Rueda BE; Kajitani GS; Ota VK; Honorato-Mauer J; Santoro ML; Bugiga AVG; Rosa JS; Asprino PF; Meneghetti P; Torrecilhas AC; Intasqui P; Bertolla RP; Foresti ML; da Graça Naffah-Mazzacoratti M; de Moraes Mello LEA; Belangero SI
    Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38664300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.
    van Erp IAM; van Essen TA; Fluiter K; van Zwet E; van Vliet P; Baas F; Haitsma I; Verbaan D; Coert B; de Ruiter GCW; Moojen WA; van der Jagt M; Peul WC
    Trials; 2021 Dec; 22(1):874. PubMed ID: 34863258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two decades of research towards a potential first anti-epileptic drug.
    Benassi SK; Alves JGSM; Guidoreni CG; Massant CG; Queiroz CM; Garrido-Sanabria E; Loduca RDS; Susemihl MA; Paiva WS; de Andrade AF; Teixeira MJ; Andrade JQ; Garzon E; Foresti ML; Mello LE
    Seizure; 2021 Aug; 90():99-109. PubMed ID: 33714677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial.
    Patel MB; McKenna JW; Alvarez JM; Sugiura A; Jenkins JM; Guillamondegui OD; Pandharipande PP
    Trials; 2012 Sep; 13():177. PubMed ID: 23013802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for Safety and Efficacy of MLC901 (NeuroAiD II) in Patients With Moderate Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Trial (ANDROMEDA).
    Chua AE; Yacapin VJ; Manalo GL; Ledesma LK
    Neurosurgery; 2023 Oct; 93(4):939-951. PubMed ID: 37129384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone for the treatment of traumatic brain injured patients with brain contusions and pericontusional edema: Study protocol for a prospective, randomized and double blind trial.
    Pérez-Bárcena J; Castaño-León AM; Lagares Gómez-Abascal A; Barea-Mendoza JA; Navarro Maín B; Pomar Pons J; Periañez Párraga LDM; Ibáñez Domínguez J; Chico-Fernández M; Llompart-Pou JA; Frontera Juan G;
    Medicine (Baltimore); 2021 Jan; 100(3):e24206. PubMed ID: 33546038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blocker use in traumatic brain injury based on the high-sensitive troponin status (BBTBBT): methodology and protocol implementation of a double-blind randomized controlled clinical trial.
    El-Menyar A; Asim M; Bahey AA; Chughtai T; Alyafai A; Abdelrahman H; Rizoli S; Peralta R; Al-Thani H
    Trials; 2021 Dec; 22(1):890. PubMed ID: 34876207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol.
    Pilipenko P; Ivanova AA; Kotsiubinskaya YV; Feigin V; Majdan M; Grigoryeva VN; Khrulev AY
    BMJ Open; 2022 Apr; 12(4):e059167. PubMed ID: 35418437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Posttraumatic Epilepsy With 1-Year Outcomes After Traumatic Brain Injury.
    Burke J; Gugger J; Ding K; Kim JA; Foreman B; Yue JK; Puccio AM; Yuh EL; Sun X; Rabinowitz M; Vassar MJ; Taylor SR; Winkler EA; Deng H; McCrea M; Stein MB; Robertson CS; Levin HS; Dikmen S; Temkin NR; Barber J; Giacino JT; Mukherjee P; Wang KKW; Okonkwo DO; Markowitz AJ; Jain S; Lowenstein D; Manley GT; Diaz-Arrastia R; ; Badjatia N; Duhaime AC; Feeser VR; Gaudette E; Gopinath S; Keene CD; Korley FK; Madden C; Merchant R; Schnyer D; Zafonte R
    JAMA Netw Open; 2021 Dec; 4(12):e2140191. PubMed ID: 34964854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: a randomized controlled trial study protocol.
    Poiani GDCR; Zaninotto AL; Carneiro AMC; Zangaro RA; Salgado ASI; Parreira RB; de Andrade AF; Teixeira MJ; Paiva WS
    Trials; 2018 Jan; 19(1):17. PubMed ID: 29310710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.